Aignostics Selected for the EIC STEP Scale Up Program

We're proud to share that Aignostics has been selected for the EIC STEP Scale Up program. This is an equity investment initiative from the European Innovation Council that supports EU start-ups in scaling strategically vital breakthrough innovations.

Eight companies were selected from the latest application round. The winners span a range of strategic technologies for Europe, including quantum computing, space transportation, clean energy, biotechnology, and AI-powered drug development. Selection for the program follows a competitive evaluation process by independent high-level experts.

Aignostics has also been awarded the STEP Seal, a quality label from the European Commission that recognizes top-rated innovation projects selected under the EIC STEP evaluation process.

Being selected to advance in the EIC STEP Scale Up process is a meaningful recognition of our mission to transform drug development and improve patient outcomes with AI for precision medicine. We're grateful to the European Innovation Council for this acknowledgment, and we look forward to continuing this work alongside our partners across Europe and beyond.